Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pharma industry asks FDA for more details on when one trial is enough

Pharmaceutical companies and industry groups are calling on the FDA to provide more details and examples about when sponsors can rely on one pivotal trial plus confirmatory evidence for a new drug’s approval. The push ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 25 September →